Top compounds associated with response to CELF5


Feature Type Standardized
Nominal ANOVA
mRNA CI-1040 GDSC1000 pan-cancer AAC -0.17 7e-07
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.18 1e-06
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 2e-06
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 2e-06
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 3e-06
mRNA Parthenolide CTRPv2 pan-cancer AAC 0.18 3e-06
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 3e-06
mRNA GSK429286A GDSC1000 pan-cancer AAC 0.16 3e-06
mRNA PD-0325901 GDSC1000 pan-cancer AAC -0.16 4e-06
mRNA 17-AAG GDSC1000 pan-cancer AAC -0.16 4e-06
Download CSV